Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiotherapy 213 Cisplatin 180 Cyclophosphamide 168 Doxorubicin 135 Paclitaxel 125 Vincristine 124 Filgrastim 121 Etoposide 103 Carboplatin 100 Methotrexate 83 Gemcitabine 82 Docetaxel 78 Cytarabine 78 Gene Expression Profiling 74 Fluorouracil 74 Prednisone 71 Granulocyte Colony-Stimulating Factor 66 Dexamethasone 66 Leucovorin 62 Polymerase Chain Reaction 47 Immunohistochemistry 46 Microarray Analysis 40 Daunorubicin 38 Irinotecan 37 Ifosfamide 37 Temozolomide 35 Cetuximab 33 Amplified Fragment Length Polymorphism Analysis 33 Peripheral Blood Stem Cell Transplantation 32 Mercaptopurine 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × Methylphenidate × Clear all

NCT00003266 2023-06-18

Methylphenidate in Treating Patients With Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡